US Patent No: 7,074,555

Number of patents in Portfolio can not be more than 2000

Detection of West Nile Virus

ALSO PUBLISHED AS: 20050244814

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method and device for detecting a West Nile Virus (WNV) infection including contacting a biological sample from a subject with an anti-IgM antibody and a recombinant WNV E polypeptide and detecting whether the polypeptide substantially binds to an antibody in the sample. The invention also includes a method and device for determining whether an animal is infected with West Nile Virus (WNV), or is either not infected or is vaccinated with a WNV vaccine.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
IDEXX LABORATORIES, INC.WESTBROOK, ME186

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chandrashekar, Ramaswamy Fort Collins, CO 43 168
Esty, Katherine Jean Westbrook, ME 4 5

Cited Art Landscape

Patent Info (Count) # Cites Year
 
CONOCO INC. (1)
2003/0022,949 Fischer-tropsch processes and catalysts using polyacrylate matrix structures 1 2002
 
MERIAL (1)
2003/0104,008 Recombinant vaccine against west nile virus 11 2002
 
MERIAL LIMITED (1)
2004/0037,848 Recombinant vaccine against West Nile Virus 10 2003
 
Other [Check patent profile for assignment information] (1)
2003/0148,261 Compositions and methods comprising West Nile virus polypeptides 13 2002

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
CRUCELL HOLLAND B.V. (5)
8,052,974 Host cell specific binding molecules capable of neutralizing viruses and uses thereof 0 2006
7,537,764 Binding molecules capable of neutralizing west nile virus and uses thereof 6 2006
7,244,430 Binding molecules capable of neutralizing West Nile virus and uses thereof 7 2007
8,211,431 Human binding molecules having killing activity against staphylococci and uses thereof 0 2007
8,460,666 Human binding molecules having killing activity against staphylococci and uses thereof 0 2012

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 11, 2018
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00